WHITE PAPER Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
Updated for 2018!
CRISPR/Cas-based gene editing technologies continue to expand the capabilities of bioscience and drug discovery researchers. Existing processes have matured, while whole new applications — such as large, exogenous insertions — open exciting possibilities for efficiently modelling human disease.
Are you taking full advantage of the latest CRISPR/Cas technology in your model design programs?
Generating In Vivo Research Models with CRISPR
Download this updated white paper to find out how CRISPR/Cas technologies can streamline and accelerate your genetic engineering projects, while costing significantly less than pre-CRISPR gene editing techniques.
You will learn:
How in-embryo CRISPR gene editing works
Which advantages and limitations of CRISPR impact your designs
When to prefer CRISPR, Easi-CRISPR, or previous editing technologies
Why incorporating CRISPR into your program can dramatically reduce project timelines